Neuroone Medical Technologies Stock Market Value
| NMTC Stock | USD 0.68 0.02 2.86% |
| Symbol | Neuroone |
Neuroone Medical Tec Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.48) | Revenue Per Share 0.158 | Quarterly Revenue Growth 0.311 | Return On Assets (1.43) | Return On Equity (3.49) |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Neuroone Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Neuroone Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Neuroone Medical.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Neuroone Medical on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Neuroone Medical Technologies or generate 0.0% return on investment in Neuroone Medical over 720 days. Neuroone Medical is related to or competes with Neuropace, Inogen, SurModics, Pulmonx Corp, Biomerica, Beyond Air, and Bluejay Diagnostics. NeuroOne Medical Technologies Corporation operates as a medical technology company More
Neuroone Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Neuroone Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Neuroone Medical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 25.16 | |||
| Value At Risk | (6.00) | |||
| Potential Upside | 9.3 |
Neuroone Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neuroone Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Neuroone Medical's standard deviation. In reality, there are many statistical measures that can use Neuroone Medical historical prices to predict the future Neuroone Medical's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.68) | |||
| Treynor Ratio | (0.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuroone Medical Tec Backtested Returns
Neuroone Medical Tec has Sharpe Ratio of -0.0299, which conveys that the firm had a -0.0299% return per unit of risk over the last 3 months. Neuroone Medical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Neuroone Medical's insignificant Risk Adjusted Performance, standard deviation of 4.67, and Mean Deviation of 3.63 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.89, which conveys possible diversification benefits within a given portfolio. Neuroone Medical returns are very sensitive to returns on the market. As the market goes up or down, Neuroone Medical is expected to follow. At this point, Neuroone Medical Tec has a negative expected return of -0.14%. Please make sure to verify Neuroone Medical's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Neuroone Medical Tec performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.67 |
Good predictability
Neuroone Medical Technologies has good predictability. Overlapping area represents the amount of predictability between Neuroone Medical time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Neuroone Medical Tec price movement. The serial correlation of 0.67 indicates that around 67.0% of current Neuroone Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Neuroone Medical Tec lagged returns against current returns
Autocorrelation, which is Neuroone Medical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Neuroone Medical's stock expected returns. We can calculate the autocorrelation of Neuroone Medical returns to help us make a trade decision. For example, suppose you find that Neuroone Medical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Neuroone Medical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Neuroone Medical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Neuroone Medical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Neuroone Medical stock over time.
Current vs Lagged Prices |
| Timeline |
Neuroone Medical Lagged Returns
When evaluating Neuroone Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Neuroone Medical stock have on its future price. Neuroone Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Neuroone Medical autocorrelation shows the relationship between Neuroone Medical stock current value and its past values and can show if there is a momentum factor associated with investing in Neuroone Medical Technologies.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Neuroone Medical Tec offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Neuroone Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neuroone Medical Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neuroone Medical Technologies Stock:Check out Neuroone Medical Correlation, Neuroone Medical Volatility and Neuroone Medical Alpha and Beta module to complement your research on Neuroone Medical. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Neuroone Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.